Prenosis

United States
Victoria, Virginia, United States, 60616

Company profile

Prenosis company profile

Prenosis is an artificial intelligence health technology company that develops data-driven diagnostic tools and precision medicine solutions for acute care conditions. It provides an AI-based platform that integrates biomarker and clinical data to generate biological insights and maps of immune response for clinical use. The company’s offerings include the Sepsis ImmunoScore diagnostic, a tool that assists clinicians by evaluating multiple clinical parameters to support assessment of sepsis risk and potential outcomes. Prenosis also supports integration of its technology into clinical workflows to help interpret complex patient data. Its platform is used to develop predictive models and evidence-based interfaces for healthcare professionals addressing fast-moving biological conditions.

Business identity

Contact email
[email protected]
Phone number
(949)246-3113
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
60616
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
7
Total equity funding
$21.5M
Last funding
Series A / $20M / 2026-01-29
Last equity funding
Series A / $20M
Investors
10
Lead investors
4
Founders
2
Articles
69

Founders and investors

Founders

Bobby Reddy, Jr.Rashid Bashir

Lead investors

Defense Threat Reduction Agency (DTRA)National Institute of General Medical ScienceNational Science FoundationPACE Healthcare Capital

Investors

Global Health Investment CorporationLabCorp Venture FundNational Science FoundationPACE Healthcare CapitalUC Investments